Standout Papers

Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advance... 2009 2026 2014 2020 521
  1. Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043) (2009)
    Stefan Sleijfer, Isabelle Ray‐Coquard et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 8 from Science/Nature 54 standout
Sub-graph 1 of 22

Citing Papers

Modular Construction of Multivariate Metal–Organic Frameworks for Luminescent Sensing
2025 Standout
Augmenting Cancer Therapy with a Supramolecular Immunogenic Cell Death Inducer: A Lysosome-Targeted NIR-Light-Activated Ruthenium(II) Metallacycle
2024 Standout
2 intermediate papers

Works of Françoise Collin being referenced

Trends in survival for patients with metastatic soft‐tissue sarcoma
2010
Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)
2009 Standout

Author Peers

Author Last Decade Papers Cites
Françoise Collin 2789 1767 1073 106 3.6k
V Le Doussal 2153 2030 859 59 3.5k
Li‐Xuan Qin 2255 1820 645 109 3.6k
Agnès Leroux 1962 1213 522 89 3.1k
Frédéric Chibon 2519 1457 661 117 4.2k
Alessandro Comandone 2269 1362 531 99 3.0k
Mary Louise Keohan 2693 2138 614 104 4.3k
Arthur P. Staddon 2366 1408 476 67 3.4k
Dominique Ranchère‐Vince 2906 1374 653 87 3.8k
David R. D’Adamo 3144 2565 807 65 4.7k
Alberto Azzarelli 2188 1339 649 54 2.7k

All Works

Loading papers...

Rankless by CCL
2026